Compounds > cytarabine

cytarabine and Leukemia, Myelomonocytic, Juvenile

cytarabine has been researched along with Leukemia, Myelomonocytic, Juvenile in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Das, G; Gupta, AK; Meena, JP; Sahoo, D; Seth, R; Wajid M, A1
Coccia, PF; Coulter, DW; Gordon, BG; Grovas, AC; Harper, JL; Patel, SA; Sanger, WG; Warkentin, PI; Wisecarver, JL1
Avdonin, P; Bobrynina, V; Kalinina, I; Khachatryan, L; Maschan, A; Maschan, M; Nasedkina, T; Novichkova, G; Solopova, G1
Alonzo, TA; Arceci, RJ; Balis, FM; Bunin, NJ; Castleberry, RP; Cheng, JW; Cooper, TM; Emanuel, PD; Gerbing, RB; Jayaprakash, N; Liu, YL; Loh, ML; Stieglitz, E; Ward, AF; Widemann, BC1
Demir Yenigürbüz, F; Gözmen, S; İrken, G; Karapınar, TH; Ören, H; Tüfekçi, Ö1
Jakovljević, G; Kardum-Skelin, I; Nakić, M; Rogosić, S1
Doisaki, S; Fukasawa, M; Fukushima, H; Fukushima, T; Hiraki, A; Kato, K; Kobayashi, C; Koike, K; Mahmoud, SS; Morishita, Y; Muramatsu, H; Nakao, T; Sumazaki, R; Suzuki, R; Yoshimi, A1

Trials

1 trial(s) available for cytarabine and Leukemia, Myelomonocytic, Juvenile

ArticleYear
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Isotretinoin; Leukemia, Myelomonocytic, Juvenile; Male; Middle Aged; Quinolones; Survival Rate; Vidarabine

2015

Other Studies

6 other study(ies) available for cytarabine and Leukemia, Myelomonocytic, Juvenile

ArticleYear
Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine.
    Pediatric hematology and oncology, 2020, Volume: 37, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Leukocyte Count; Mercaptopurine; Platelet Count; Remission Induction; Retrospective Studies; Spleen; Treatment Outcome

2020
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:6

    Topics: Antimetabolites, Antineoplastic; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Mitoxantrone; Recurrence; Retreatment; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous

2014
Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:10

    Topics: Age of Onset; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Genes, ras; Humans; Infant; Isotretinoin; Leukemia, Myelomonocytic, Juvenile; Mutation; Purpura, Thrombotic Thrombocytopenic; Sirolimus

2014
Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2015, Volume: 32, Issue:2

    Topics: Abnormalities, Multiple; Allografts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Cytarabine; Exons; Female; Genes, ras; Genetic Heterogeneity; Germ-Line Mutation; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Mercaptopurine; Mutation, Missense; Point Mutation; Prednisolone; Proto-Oncogene Proteins c-cbl; Remission Induction

2015
Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.
    Collegium antropologicum, 2010, Volume: 34, Issue:1

    Topics: Antimetabolites, Antineoplastic; Biopsy, Fine-Needle; Cytarabine; Eosine Yellowish-(YS); Female; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Mercaptopurine; Methylene Blue; Protein Tyrosine Phosphatase, Non-Receptor Type 11

2010
Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy.
    International journal of hematology, 2012, Volume: 95, Issue:5

    Topics: Antimetabolites, Antineoplastic; Brain; Cytarabine; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Mercaptopurine; Stem Cell Transplantation

2012